Vontobel Holding’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-37,398
| Closed | -$691K | – | 1157 |
|
|
2024
Q3 | $691K | Sell |
37,398
-1,146
| -3% | -$21.2K | ﹤0.01% | 689 |
|
|
2024
Q2 | $830K | Sell |
38,544
-4,156
| -10% | -$89.5K | ﹤0.01% | 615 |
|
|
2024
Q1 | $1.15M | Sell |
42,700
-840
| -2% | -$22.6K | 0.01% | 545 |
|
|
2023
Q4 | $1.3M | Buy |
+43,540
| New | +$1.3M | 0.01% | 526 |
|
|
2023
Q2 | – | Sell |
-49,799
| Closed | -$853K | – | 1141 |
|
|
2023
Q1 | $853K | Sell |
49,799
-8,651
| -15% | -$148K | 0.01% | 630 |
|
|
2022
Q4 | $1.14M | Buy |
+58,450
| New | +$1.14M | 0.01% | 539 |
|
|
2022
Q2 | – | Sell |
-36,912
| Closed | -$589K | – | 1104 |
|
|
2022
Q1 | $589K | Sell |
36,912
-1,606
| -4% | -$25.6K | 0.01% | 745 |
|
|
2021
Q4 | $883K | Buy |
+38,518
| New | +$883K | 0.01% | 668 |
|
|
2021
Q3 | – | Sell |
-6,955
| Closed | -$301K | – | 1218 |
|
|
2021
Q2 | $301K | Sell |
6,955
-41,391
| -86% | -$1.79M | ﹤0.01% | 914 |
|
|
2021
Q1 | $2.15M | Buy |
48,346
+1,026
| +2% | +$45.5K | 0.02% | 382 |
|
|
2020
Q4 | $3.12M | Buy |
+47,320
| New | +$3.12M | 0.02% | 306 |
|